MedPath

Dapoxetine

Generic Name
Dapoxetine
Drug Type
Small Molecule
Chemical Formula
C21H23NO
CAS Number
119356-77-3
Unique Ingredient Identifier
GB2433A4M3

Overview

Dapoxetine is a selective serotonin reuptake inhibitor, for the treatment of premature ejaculation. In a phase II proof-of-concept study conducted by PPD, dapoxetine demonstrated a statistically significant increase in ejaculatory latency when compared to placebo. Alza submitted a NDA to the FDA for dapoxetine for the treatment of premature ejaculation in December 2004. In October 2005, the company received a FDA Non-Approvable letter from the FDA, at which time they planned to work with regulators to address outstanding questions.

Background

Dapoxetine is a selective serotonin reuptake inhibitor, for the treatment of premature ejaculation. In a phase II proof-of-concept study conducted by PPD, dapoxetine demonstrated a statistically significant increase in ejaculatory latency when compared to placebo. Alza submitted a NDA to the FDA for dapoxetine for the treatment of premature ejaculation in December 2004. In October 2005, the company received a FDA Non-Approvable letter from the FDA, at which time they planned to work with regulators to address outstanding questions.

Indication

For the treatment of premature ejaculation.

Associated Conditions

  • Premature Ejaculation

Clinical Trials

View More Clinical Trials

Sign in to access the complete clinical trial database with detailed study information.

Title
Posted
Study ID
Phase
Status
Sponsor
2005/09/21
Phase 3
Completed
Alza Corporation, DE, USA

FDA Approved Products

View More FDA Products

Sign in to access additional FDA-approved products with detailed regulatory information.

Product Name
Manufacturer
Route
Strength
Approved
NDC Code

No FDA products found

No FDA products found for this drug

EMA Approved Products

View More EMA Products

Sign in to access additional EMA-approved products with authorization details.

Medicine Name
EMA Number
Auth. Holder
Country
Drug Type
Status
Issued
Opinion
Revision

No EMA products found

No EMA products found for this drug

HSA Approved Products

View More HSA Products

Sign in to access additional HSA-approved products with regulatory information.

Product Name
Manufacturer
Dosage Form
Strength
Approved
Approval No.

No HSA products found

No HSA products found for this drug

NMPA Approved Products

View More NMPA Products

Sign in to access additional NMPA-approved products with approval information.

Product Name
Approval No.
Manufacturer
Dosage Form
Trade Name
Strength
Type
Status
Date
Import
国药准字H20249570
片剂
N/A
30mg(按C₂₁H₂₃NO计)
Chemical Drug
Approved
2024/12/01
Domestic
国药准字H20249684
片剂
N/A
30mg(按C₂₁H₂₃NO计)
Chemical Drug
Approved
2024/12/06
Domestic
国药准字H20243544
片剂
N/A
30mg(按C₂₁H₂₃NO计)
Chemical Drug
Approved
2024/04/17
Domestic
国药准字H20243216
片剂
N/A
30mg(按C₂₁H₂₃NO计)
Chemical Drug
Approved
2024/02/23
Domestic
国药准字H20244118
片剂
N/A
60mg(按C₂₁H₂₃NO计)
Chemical Drug
Approved
2024/06/25
Domestic
国药准字H20223926
片剂
N/A
30mg(按C₂₁H₂₃NO计)
Chemical Drug
Approved
2022/12/30
Domestic
国药准字H20203553
片剂
N/A
60mg(按C21H23NO计)
Chemical Drug
Approved
2020/11/04
Domestic
国药准字H20234541
片剂
N/A
30mg(按C₂₁H₂₃NO计)
Chemical Drug
Approved
2023/11/21
Domestic
国药准字H20234684
片剂
N/A
60mg(按C₂₁H₂₃NO计)
Chemical Drug
Approved
2023/12/26
Domestic
国药准字H20234304
片剂
N/A
30mg(按C₂₁H₂₃NO计)
Chemical Drug
Approved
2023/10/18
Domestic

PPB Approved Products

Product Name
Registration Code
Company
Category
Sale Type
Reg. Date

No PPB products found

No PPB products found for this drug

TGA Approved Products

View More TGA Products

Sign in to access additional TGA-approved products with licensing information.

Product Name
ARTG ID
Sponsor
Status
Reg. Date
Ingredient

No TGA products found

No TGA products found for this drug

© Copyright 2025. All Rights Reserved by MedPath